戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 er drugs, a phenomenon termed 'incubation of drug craving'.
2 ch can at times be maladaptive (for example, drug cravings).
3 ies in brain structures involved in food and drug craving.
4 praisal as associated with lower cue-induced drug craving.
5  (vmPFC) activity positively correlated with drug craving.
6 statement of drug seeking, and incubation of drug craving.
7  ensembles in this new form of incubation of drug craving.
8 exposure to drug-associated cues that induce drug craving.
9 ned despite adverse consequences and intense drug craving.
10 ous opioids in the neural systems underlying drug craving.
11 entral striatum were associated with intense drug craving.
12 sue that is frequently caused by cue-induced drug craving.
13 sity to engage in drug-seeking behavior, and drug craving.
14 th the conditioned place preference model of drug craving.
15  cocaine and whether this is associated with drug craving.
16 ion, including those that mediate reward and drug craving.
17 ssociated drug craving, termed incubation of drug craving.
18 rence for partner odors over cocaine buffers drug craving.
19  be important for understanding the basis of drug craving, a key factor in the maintenance of substan
20 use disorder (HUD) have been associated with drug craving, a reliable predictor of treatment outcomes
21 duced an animal model to study incubation of drug craving after prolonged voluntary abstinence, mimic
22  here may have implications for cue-elicited drug craving after repeated exposure to drugs of abuse.
23 amatergic synapses that lead to endurance of drug craving and addiction are poorly understood.
24 ues that are associated with self-reports of drug craving and appear to be of a greater magnitude tha
25 e findings support the use of stress-induced drug craving and associated hypothalamic-pituitary-adren
26 cortex (PFC) can cause lasting reductions in drug craving and consumption.
27 h stress and drug cue exposure each increase drug craving and contribute to relapse in cocaine depend
28  a novel animal model to study incubation of drug craving and cue-induced drug seeking after prolonge
29                                  Cue-induced drug craving and disinhibition are two essential compone
30 ng the neurobiological processes that incite drug craving and drive relapse has the potential to help
31                      An insidious feature of drug craving and drug seeking in humans is that it can b
32 entiation that may contribute to cue-induced drug craving and drug-seeking behavior.
33       Addiction-associated behaviors such as drug craving and relapse are hypothesized to result from
34  inhibition of this system may contribute to drug craving and relapse in addicted subjects.
35                 Environmental stimuli elicit drug craving and relapse in cocaine users by triggering
36                      Evidence indicates that drug craving and relapse in humans are often provoked by
37 e use produces neuroadaptations that support drug craving and relapse in substance use disorders (SUD
38                                              Drug craving and relapse to drug use during abstinence a
39 process thought to underlie the emergence of drug craving and relapse to drug use.
40 ct neuroimmune adaptations that may increase drug craving and relapse vulnerability in humans.
41 rly long-lived aspects of addiction, such as drug craving and relapse, and to identify specific genes
42                            In a rat model of drug craving and relapse, cue-induced drug seeking progr
43 o develop medications that effectively treat drug craving and relapse, the core features of addictive
44  the neurobiological factors responsible for drug craving and relapse, with promising therapeutic imp
45 ptible to environmental stimuli that trigger drug craving and relapse.
46 cocaine-seeking behavior, an animal model of drug craving and relapse.
47 uding taste processing, and is implicated in drug craving and relapse.
48 lated cues, leading to an intensification of drug craving and relapse.
49 ation by cue-associated activity, triggering drug craving and relapse.
50 ith drug reward can be powerful triggers for drug craving and relapse.
51                                              Drug craving and seeking can increase during a period of
52 y inform therapeutic mechanisms for reducing drug craving and seeking in heroin addiction.
53 ated with previous drug exposure can trigger drug craving and seeking, and form a substantial obstacl
54 tive states, has recently been implicated in drug craving and social stress.
55 ceptor agonists in decreasing stress-induced drug craving and stress-induced initial heroin lapse.
56 n lead to SUD symptoms, including compulsive drug craving and taking.
57 s like BP 897 could be used for reducing the drug craving and vulnerability to relapse that are elici
58 the salient drug-associated cues can lead to drug cravings and drug seeking behavior.
59  and differences in the neural correlates of drug cravings and gambling urges in CD and PG.
60  potential adjunctive treatment for reducing drug cravings and use in individuals with severe opioid
61 ncrease the likelihood of relapse by evoking drug craving, and brain-imaging studies have identified
62 dels in addition to baseline and cue-induced drug craving, and other clinical outcome variables (mood
63           Importantly, stress contributes to drug craving, and there is evidence for overlap between
64 hlight sex-specific effects of guanfacine on drug craving, anxiety, and negative mood with significan
65  brain regions involved in the incubation of drug craving, as well as evidence for the underlying cel
66 ere no differences between the two groups in drug craving, depressed mood, anxiety, or Clinical Globa
67 nd induced relief of withdrawal symptoms and drug cravings, despite acting on the same opioid recepto
68 ental procedures used to study incubation of drug craving do not incorporate negative consequences of
69 the medial prefrontal cortex associated with drug craving, effective treatments are still elusive.
70  exposure to drug-associated cues, provoking drug craving even after prolonged abstinence.
71 eloped for mouse brains, while incubation of drug craving has primarily been studied in rats, and inc
72 gaine results in a long-lasting reduction of drug craving (humans) and drug and alcohol intake (roden
73  in synaptic activity related to cue-induced drug craving in 8 crack cocaine-dependent African Americ
74 f regions previously shown to be involved in drug craving in addicted subjects (orbitofrontal cortex,
75    It was suggested in 1986 that cue-induced drug craving in cocaine addicts progressively increases
76 del the altered brain states responsible for drug craving in human drug addicts.
77 anding the neurobiology of the incubation of drug craving in rodents is likely to have significant im
78                The incubation of cue-induced drug craving in rodents provides a model of persistent v
79  of withdrawal from cocaine, suggesting that drug craving incubates over time.
80                        Such an incubation of drug craving is not specific to cocaine, as similar find
81                                 Cue-elicited drug-craving is a cardinal feature of addiction that int
82 d animal models and associated with enhanced drug craving, is eliminated in flies mutant for period,
83 itization is proposed to model the increased drug craving observed in human psychostimulant abusers.
84 s was associated with self-ratings of robust drug craving or anger, and comparable alterations in hea
85          The subjects indicated the onset of drug craving or emotional response, allowing comparison
86 research target with the potential to reduce drug craving or seeking behaviors.
87 ics vs whites: OR, 0.48; 95% CI, 0.24-0.95), drug craving (OR, 2.78; 95% CI, 1.54-5.02), chronic illn
88  drug action and thereby partially alleviate drug craving, or that affect the addiction process per s
89 enomenon referring to the intensification of drug craving over extended abstinence.
90 ked by pathological drug seeking and intense drug craving, particularly in response to drug-related s
91                                  Cue-induced drug craving progressively intensifies after withdrawal
92               In the classical incubation of drug craving rat model, drug seeking is assessed after h
93 ther relapse models, including incubation of drug craving, reacquisition and resurgence models, and p
94                                Incubation of drug craving refers to time-dependent increases in drug
95 luence of ibudilast on subjective (including drug craving), reinforcing, and analgesic effects of oxy
96  is progressively intensified cue-associated drug craving, termed incubation of drug craving.
97 ntribute to the impaired decision making and drug craving that characterize cocaine withdrawal.
98 addiction retain some degree of control over drug craving that correlates with neural activity in the
99 homotor sensitization and the development of drug craving-that are associated with chronic use of add
100 ce from the drug and tests for incubation of drug craving (the time-dependent increase in drug seekin
101 reinforced responding, and the incubation of drug craving (the time-dependent increase in drug seekin
102  cocaine use disorders is the "incubation of drug craving" - the drive for the drug increases the lon
103   Here, we used a rat model of incubation of drug craving, the neuronal activity marker Fos, and the
104 ed frontal lobe contributions to cue-induced drug craving under different intertemporal drug availabi
105               Cocaine abusers may experience drug craving upon exposure to environmental contexts whe
106 l imagery control condition, imagery-induced drug craving was associated with bilateral (right hemisp
107 nger control condition, internally generated drug craving was associated with bilateral activation of
108                         Using a rat model of drug craving, we found that the responsiveness to cocain
109                      Depressive symptoms and drug craving were also correlated with opioid use in MMP
110 ips between these measures and self-reported drug craving were examined.
111          Subjective effects of oxycodone and drug craving were measured with visual analog scales (VA

 
Page Top